Exploring What’s Possible With COVID-19 Trials and Kidney Disease
With the impact of coronavirus disease 2019 (COVID-19) evident in patients with renal disease, a discussion at Kidney Week focused on ways to engage them in clinical trials.
With the impact of coronavirus disease 2019 (COVID-19) evident in patients with renal disease, a discussion at Kidney Week focused on ways to engage them in clinical trials.
In an interview during The American Journal of Managed Care®’s Institute for Value-Based Medicine® event, held with Sutter Health, Ryan Stice, PharmD, BCPS, explains the…
The Senate Finance Committee has introduced bipartisan legislation that proposes using Medicaid and Medicare programs to help prevent and reduce generic drug shortages; US indicators…
Speakers discussed the disparities in prostate-specific antigen (PSA) screening rates among different racial groups and explored the potential of free PSA percentage as a predictive…
Quoc-Dien Trinh, MD, MBA, chief of urology at Brigham & Women’s Faulkner Hospital, highlighted successful efforts to improve prostate cancer care access for underserved communities…
Older patients with chronic obstructive pulmonary disease (COPD) and anxiety exhibited exacerbated symptoms, increased comorbidities, and frequent acute exacerbations of COPD (AECOPD), emphasizing the need…
About 5000 leaders in health economics and outcomes research will gather for the 2024 meeting, which has the theme, “HEOR: A Transformative Force for Whole Health.”
A recent meta-analysis that assessed prescribed exercise in managing multiple sclerosis (MS) detailed the benefits of resistance training for improving muscle weakness in this patient…
Darius Lakdawalla, PhD, director of research, Schaeffer Center for Health Policy & Economics at the University of Southern California, discusses the growing importance of value…
About 5000 leaders in health economics and outcomes research will gather for the 2024 meeting, which has the theme, “HEOR: A Transformative Force for Whole Health.”
In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total…